Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Epithelial-Mesenchymal Transition in Metastatic Colorectal Cancer

In: Gastrointestinal Cancers [Internet]. Brisbane (AU): Exon Publications; 2022 Sep 30. Chapter 3.
Affiliations
Free Books & Documents
Review

Epithelial-Mesenchymal Transition in Metastatic Colorectal Cancer

Jose Andres Morgado-Diaz et al.
Free Books & Documents

Excerpt

Epithelial-mesenchymal transition (EMT) is a morphogenetic event during which cells lose their epithelial characteristics, such as apicobasal polarity, and gain mesenchymal features with an increased migratory and invasive potential. A wide range of studies have shown that this event plays a crucial role in tumor progression and metastasis. The results of the studies also demonstrate participation of EMT in therapy resistance and in the development and maintenance of stemness potential in colorectal cancer. In addition, evidence from preclinical and early clinical studies have shown that EMT markers might serve as outcome predictors and potential therapeutic targets in colorectal cancer. In this chapter, we discuss the fundamentals of EMT, including cell-cell adhesion disruption and cell polarity loss, actin cytoskeleton reorganization, transcription factors, and post-translational modifications associated with EMT. We also discuss EMT-mediated mechanisms of resistance to radiotherapy and chemotherapy. Finally, we provide a summary of EMT components and their use as potential markers or therapeutic targets for metastasis inhibition, along with the obstacles in the development of drugs targeting EMT.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors declare no potential conflict of interest with respect to research, authorship, and/or publication of this manuscript.

References

    1. Sung H, Ferlay J, Siegel JR, Laversanne M, Soerjomataram I, Jemal H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660 . - DOI - PubMed
    1. Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21(6):341–352. https://doi.org/10.1038/s41580-020-0237-9 . - DOI - PMC - PubMed
    1. Ye X, Weinberg RA. Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol. 2015;25(11):675–86. https://doi.org/10.1016/j.tcb.2015.07.012 . - DOI - PMC - PubMed
    1. Amack JD. Cellular dynamics of EMT: lessons from live in vivo imaging of embryonic development. Cell Commun Signal. 2021;19(1):79. https://doi.org/10.1186/s12964-021-00761-8 . - DOI - PMC - PubMed
    1. Rocha MR, Morgado-Diaz JA. Epithelial-Mesenchymal Transition in colorectal cancer: Annexin A2 is caught in the crosshairs. J Cell Mol Med. 2021;25(22):10774–10777. https://doi.org/10.1111/jcmm.16962 . - DOI - PMC - PubMed

LinkOut - more resources